510(k) device
Embryo Predict
Alife Health · Embryo Image Assessment System, Assisted Reproduction (PBH, Class II) · First FDA decision May 15, 2026, newest May 15, 2026Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
7
Naming "Embryo Predict"
MAUDE reports
0
Brand "Embryo Predict", since 2015
PubMed studies
0
Mentioning "Embryo Predict"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Embryo Predict
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Embryo Predict510(k)
K250781 · Decided May 15, 2026 · 427 days after receipt
Device type: Embryo Image Assessment System, Assisted Reproduction (PBH) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Embryo Predict", any status and sponsor, newest update first.
- Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for TransferPivotal-lookingCompleted
Alife HealthNot on our public-company list
NCT05483985 · 444 participants · Start Jul 11, 2022 · Primary completion Sep 19, 2024
Device: Hera Score · For: Infertility
Sites: Menlo Park, California; San Ramon, California; Margate, Florida · 7 sites in all
Future Fertility Inc.Not on our public-company list
NCT07464275 · 76 participants · Start Apr 22, 2026 · Primary completion May 25, 2026
Device: MAGENTA Blast · For: Fertility Disorders; Infertility
Sites: Toronto, Canada
Instituto Valenciano de Infertilidad, IVI VALENCIAAcademic, hospital or other
NCT05440019 · 20 participants · Start Sep 14, 2022 · Primary completion Apr 26, 2023
Device: IMAGE CAPTURE SESSION · For: Infertility, Female
Sites: Valencia, Spain
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Embryo Predict", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PBH
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Embryo Predict"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PBH.
- Magenta BlastFuture Fertility, Inc. · 510(k) 2026
- Chloe BlastFairtility , Ltd. · 510(k) 2025
- KIDScore D3Vitrolife A/S · 510(k) 2019
- Eeva SystemAuxogyn, Inc. · 510(k) 2014
- Eeva 2.0Auxogyn, Inc. · De Novo 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.